Centessa Pharmaceuticals PLC ADR (CNTA NASDAQ) stock market data APIs
$29.8515
-0.75(-2.5%)
as of December 5, 2025
Try our APIs with
free plan!
Centessa Pharmaceuticals PLC ADR Financial Data Overview
Price chart is built with
Anychart
Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines. Its lead clinical-stage program includes ORX750, an orally administered OX2R agonist in a Phase 2a study for the treatment of idiopathic hypersomnia and narcolepsy type 1 and 2. The company also develops ORX142 for the treatment of neurological and neurodegenerative disorders, as well as other potential symptoms, including excessive daytime sleepiness, impaired attention, cognitive deficits, and fatigue; and ORX489 for the treatment of neuropsychiatric disorders. In addition, it offers LockBody, which is designed to selectively drive potent effector function activity, such as CD3, into the tumor microenvironment. Centessa Pharmaceuticals plc was incorporated in 2020 and is headquartered in Altrincham, the United Kingdom.
Prev. Close
29.8515
Open
29.1061
High
29.8771
Low
28.8986
52 wk Range
9.6-30
Market Cap
4 369 M
Shares Outstanding
146 M
Revenue
15 000 K
EPS
-0.41
Beta
1.56
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Centessa Pharmaceuticals PLC ADR (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Centessa Pharmaceuticals PLC ADR data using free add-ons & libraries
Get Centessa Pharmaceuticals PLC ADR Fundamental Data
Centessa Pharmaceuticals PLC ADR Fundamental data includes:
- Net Revenue: 15 000 K
- EBITDA: -213 490 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-05
- EPS/Forecast: -0.3883
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Centessa Pharmaceuticals PLC ADR News
New
Ashland, Bitdeer, and More Stocks See Action From Activist Investors
Activists also report to the SEC on Dianthus Therapeutics, Centessa Pharmaceuticals, and Insight Enterprises. Continue Reading
What One Fund's Sale of Centessa Stock Signals About the Fast-Rising Biotech Company
Key Points San Francisco-based 5AM Venture Management sold 150,000 CNTA shares in the third quarter. Despite the sale, the stock's sharp rally last quarter led the fund's net position value in CNTA t...
What One Fund's Sale of Centessa Stock Signals About the Fast-Rising Biotech Company
Key Points San Francisco-based 5AM Venture Management sold 150,000 CNTA shares in the third quarter. Despite the sale, the stock's sharp rally last quarter led the fund's net position value in CNTA t...
5AM Venture Just Dumped Its Viking Stake—Smart Call or Missed Opportunity?
Key Points Exited entire position: down 189,593 shares, a net position change of $5.02 million No remaining shares held; post-trade stake is zero The position previously accounted for approximately 1...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
